An alteration in the membrane localization of the ABCG2 and ABCB1 transporters (i.e., the transporters would not be located in the cell cytoplasmic membrane and thus can not efflux the anticancer drugs from the colon cancer cells) could decrease the resistance to the anticancer drugs. This evidence concerns the gene ABCG2 and malignant colon neoplasm.